July marked the biggest income month in Medical Marijuana Inc’s (OTC:MJNA) historical past.
Blake Schroeder, CEO of Medical Marijuana, appeared on Benzinga’s Youtube show “Cannabis Hour” for an unique interview Thursday.
Medical Marijuana was the primary publicly listed hashish firm, Schroeder instructed Benzinga.
The corporate created the non-psychoactive hashish area and launched the world’s first CBD merchandise, the Medical Marijuana CEO mentioned: “I actually suppose we have modified the world.”
Medical Marijuana goals to be the world’s first international hashish firm by introducing non-psychoactive hashish and breaking down the authorized boundaries to entry, he mentioned.
The corporate first launched within the U.S. It expanded to Europe in 2018, adopted by Japan in 2019. Medical Marijuana now has its sights set on a “huge Asian growth,” Schroeder mentioned, noting the corporate plans to start promoting its merchandise in Hong Kong within the fall.
“Issues want to alter in that a part of the world. All all through the Asian neighborhood, you may go to jail for having CBD. I imply that’s loopy,” he emphasised. “This is part of the world that should begin considering slightly bit in another way I feel … and our firm intends to cleared the path.”
Schroeder went on to speak about outdated hashish legal guidelines internationally, Delta 8 THC, what buyers ought to anticipate from Medical Marijuana and extra.
See the complete interview right here:
MJNA Worth Motion: Medical Marijuana has traded as excessive as $0.22 and as little as $0.013 cents over a 52-week interval.
The inventory is up 64.25% year-to-date.
© 2021 Benzinga.com. Benzinga doesn’t present funding recommendation. All rights